466 results
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
Bright future ahead for tricuspid regurgitation management
19 May 2022 – From EuroPCR 2022
In this conversation between Philipp Lurz and Felix Kreidel, recorded for EuroPCR 2022, learn more about the bRIGHT study and the latest outcomes released, and further understand TriClip therapy real-world outcomes applicability in daily practice.
View more videos and course resources here!
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Innovations in simulation-based training, procedural planning, monitoring and robotic PCI
17 May 2022 – From EuroPCR 2022
In this session, find out more about telemedicine, mixed reality technology in CTO proctoring, new-human grade simulator for ViV procedure planning, distance proctoring for transseptal TMVR, stent positioning assistance system, and robotic PCI.
PCR Tricuspid Focus Group update: present and future of tricuspid regurgitation treatment
17 May 2022 – From EuroPCR 2022
Follow the discussions based on the case of an 85-year-old male patient with HTN, mild secondary PAH, DCM, LVEF 45 %, and surgical bioAVR and MVR, presenting with progressive SOB and signs of right HF, severe secondary TR 4/5, and permanent AF, and note the indications of...
Native right ventricular outflow tract valve implantation
15 Jun 2022
This case has been accredited by EBAC with 1 CME credit
An 8-year-old boy with Tetralogy of Fallot underwent surgical correction with ventricular septal defect closure and transannular patch at the age of 16 months. PO was complicated by heart failure and sepsis. He now presents with mild tricuspid regurgitation...
Author
Author
PCRonline @ ACC 2022 Scientific Sessions
29 Mar 2022
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation
22 Mar 2022
Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.
Author
Author
